×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
山东大学 [21]
内容类型
期刊论文 [21]
发表日期
2019 [2]
2018 [6]
2017 [5]
2016 [6]
2015 [1]
2014 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共21条,第1-10条
帮助
限定条件
内容类型:期刊论文
专题:山东大学
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Local Thermal Ablation with Continuous EGFR Tyrosine Kinase Inhibitors for EGFR-Mutant Non-small Cell Lung Cancers that Developed Extra-Central Nervous System (CNS) Oligoprogressive Disease
期刊论文
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2019, 卷号: 42, 期号: 5, 页码: 693-699
作者:
Ni, Yang
;
Liu, Baodong
;
Ye, Xin
;
Fan, Weijun
;
Bi, Jingwang
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2019/12/11
Thermal ablation
Microwave ablation
Radiofrequency ablation
EGFR-TKI
acquired resistance
Oligoprogression
Association of radiomic features with epidermal growth factor receptor mutation status in non-small cell lung cancer and survival treated with tyrosine kinase inhibitors
期刊论文
Nuclear medicine communications, 2019, 卷号: 40, 期号: 11, 页码: 1091-1098
作者:
Wang C.
;
Dong X.
;
Sun X.
;
Zhang R.
;
Xing L.
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/11
Advances in studies of tyrosine kinase inhibitors and their acquired resistance
期刊论文
MOLECULAR CANCER, 2018, 卷号: 17
作者:
Jiao, Qinlian
;
Bi, Lei
;
Ren, Yidan
;
Song, Shuliang
;
Wang, Qin
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/11
Cancer
Protein tyrosine kinase
Tyrosine kinase inhibitors
Acquired
resistance
Revisiting the molecular mechanism of acquired resistance to reversible tyrosine kinase inhibitors caused by EGFR gatekeeper T790M mutation in non-small-cell lung cancer
期刊论文
MEDICINAL CHEMISTRY RESEARCH, 2018, 卷号: 27, 期号: 9, 页码: 2160-2170
作者:
Zhao, Yan
;
Jiao, Yingjie
;
Sun, Fengzhe
;
Liu, Xudong
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/11
Epidermal growth factor receptor
Gatekeeper T790M mutation
Tyrosine
kinase inhibitor
Acquired resistance
Non-small-cell lung cancer
Leukocyte Telomere Length and Clinical Outcomes of Advanced Lung Adenocarcinoma Patients with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment
期刊论文
DNA AND CELL BIOLOGY, 2018, 卷号: 37, 期号: 11, 页码: 903-908
作者:
Li, Ji
;
Zhang, Li
;
Zhu, Hui
;
Pan, Wenting
;
Zhang, Nasha
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2019/12/11
telomere length
leukocyte
EGFR-TKI
gefitinib
survival
Interactions between EGFR and PD-1/PD-L1 pathway: Implications for treatment of NSCLC
期刊论文
CANCER LETTERS, 2018, 卷号: 418, 页码: 1-9
作者:
Li, Xue
;
Lian, Zhen
;
Wang, Shuai
;
Xing, Ligang
;
Yu, Jinming
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/11
Non-small cell lung cancer
Epidermal growth factor receptor
Programmed
cell death receptor/ligand 1
tyrosine kinase inhibitors
Development of Bruton's Tyrosine Kinase Inhibitors for Rheumatoid Arthritis
期刊论文
CURRENT MEDICINAL CHEMISTRY, 2018, 卷号: 25, 期号: 42, 页码: 5847-5859
作者:
Lv, Jiahui
;
Wu, Jingde
;
He, Feng
;
Qu, Ying
;
Zhang, Qiuqiong
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/11
BTK inhibitor
RA
B cell
activity
anti-inflammatory
structure
Targeting Bruton's tyrosine kinase for the treatment of B cell associated malignancies and autoimmune diseases: Preclinical and clinical developments of small molecule inhibitors
期刊论文
ARCHIV DER PHARMAZIE, 2018, 卷号: 351, 期号: 7
作者:
Zhang, Zhen
;
Zhang, Daoguang
;
Liu, Yang
;
Yang, Dezhi
;
Ran, Fansheng
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/11
arthritis
Bruton's tyrosine kinase
BTK inhibitor
leukemia
lymphoma
Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations
期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 34, 页码: 56714-56725
作者:
Wei, Zhigang
;
Ye, Xin
;
Yang, Xia
;
Zheng, Aimin
;
Huang, Guanghui
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/11
epidermal growth factor receptor
tyrosine kinase inhibitors
non-small
cell lung cancer
microwave ablation
progression free survival
Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases
期刊论文
慢性疾病与转化医学, 2017, 卷号: 3, 期号: 4, 页码: 221-229
作者:
Kong Lingling
;
Wang Linlin
;
Xing Ligang
;
Yu Jinming
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/12/11
Non-small cell lung cancer
Brain metastases
Epidermal growth factor receptor mutation
Tyrosine kinase inhibitors
Therapeutic outcomes
©版权所有 ©2017 CSpace - Powered by
CSpace